Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -35.50% is 74% above its 5-year average of -134.72%, near the high end of its 5-year range (-437.57%–-10.09%).
96.40% below its 12-month average of -18.07%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -11.83%.
RETURN ON ASSETS (ROA)
-35.50%
RETURN ON ASSETS (ROA) AVG TTM
-18.07%
RETURN ON ASSETS (ROA) AVG 3Y
-62.20%
RETURN ON ASSETS (ROA) AVG 5Y
-134.72%
RETURN ON ASSETS (ROA) AVG 10Y
-108.75%
RETURN ON ASSETS (ROA) AVG 15Y
-95.51%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-96.40%
CURRENT VS 3Y AVG
+42.92%
CURRENT VS 5Y AVG
+73.65%
CURRENT VS 10Y AVG
+67.36%
CURRENT VS 15Y AVG
+62.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.94%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
-14.74%
vs the sector median at left
LifeMD, Inc.
Market Cap
$134.21M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
Market Cap
$133.75M
Return on Assets (ROA)
10.55%
TTM Avg
-7.15%
3Y Avg
-30.40%
5Y Avg
-23.45%
Market Cap
$133.38M
Return on Assets (ROA)
-73.85%
TTM Avg
-21.75%
3Y Avg
-19.65%
5Y Avg
-19.48%
Market Cap
$133.05M
Return on Assets (ROA)
-161.55%
TTM Avg
-68.10%
3Y Avg
-58.95%
5Y Avg
-64.88%
Market Cap
$135.45M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$136.50M
Return on Assets (ROA)
-33.22%
TTM Avg
-27.55%
3Y Avg
-27.55%
5Y Avg
-27.55%
Market Cap
$137.11M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$139.47M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMD) | $134.21M | -35.50% | -18.07% | -62.20% | -134.72% |
| Organigram Global Inc. (OGI)vs › | $133.75M | 10.55% | -7.15% | -30.40% | -23.45% |
| Freenome, Inc. (FRNM)vs › | $134.87M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $133.38M | -73.85% | -21.75% | -19.65% | -19.48% |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.05M | -161.55% | -68.10% | -58.95% | -64.88% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.45M | -6.07% | -5.08% | -4.92% | -1.70% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.50M | -33.22% | -27.55% | -27.55% | -27.55% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | -6.51% | -15.82% | -25.09% | -19.08% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -36.33% | -27.39% | -256.74% | -207.88% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 35.31% | -14.11% | -23.46% | -20.68% |
ROA
-35.5%
ROE
-266.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -10.09% |
| 2024-12-31 | -26.06% |
| 2023-12-31 | -35.22% |
| 2022-12-31 | -177.42% |
| 2021-12-31 | -121.98% |
| 2020-12-31 | -437.57% |
| 2019-12-31 | -91.03% |
| 2018-12-31 | -47.43% |
| 2017-12-31 | -95.42% |
| 2016-12-31 | -140.23% |
| 2015-12-31 | -13.82% |
| 2014-12-31 | -262.80% |
| 2013-12-31 | -48.65% |
| 2012-12-31 | -120.55% |
| 2011-12-31 | -146.49% |
